
NSF Org: |
CBET Division of Chemical, Bioengineering, Environmental, and Transport Systems |
Recipient: |
|
Initial Amendment Date: | July 19, 2018 |
Latest Amendment Date: | July 19, 2018 |
Award Number: | 1841539 |
Award Instrument: | Standard Grant |
Program Manager: |
Leon Esterowitz
CBET Division of Chemical, Bioengineering, Environmental, and Transport Systems ENG Directorate for Engineering |
Start Date: | August 15, 2018 |
End Date: | July 31, 2020 (Estimated) |
Total Intended Award Amount: | $300,000.00 |
Total Awarded Amount to Date: | $300,000.00 |
Funds Obligated to Date: |
|
History of Investigator: |
|
Recipient Sponsored Research Office: |
506 S WRIGHT ST URBANA IL US 61801-3620 (217)333-2187 |
Sponsor Congressional District: |
|
Primary Place of Performance: |
IL US 61820-7473 |
Primary Place of
Performance Congressional District: |
|
Unique Entity Identifier (UEI): |
|
Parent UEI: |
|
NSF Program(s): | EFRI Research Projects |
Primary Program Source: |
|
Program Reference Code(s): |
|
Program Element Code(s): |
|
Award Agency Code: | 4900 |
Fund Agency Code: | 4900 |
Assistance Listing Number(s): | 47.041 |
ABSTRACT
This project will develop and demonstrate a unique live-tissue imaging platform that can detect the presence of opioids in live brain slices from mice, and image their effects on the cellular metabolism and coupled neural brain activity. This platform will allow the first visualization of how the presence of opioids affects the metabolism of neurons and astrocytes, and the subsequent neural spontaneous depolarization activity. The establishment and demonstration of this imaging platform will enable future comparative studies using morphine (the prototypical opioid), caffeine, and dopamine to elucidate how opioids differ from non-addictive compounds (e.g. caffeine and anesthetics) and prevalent neurotransmitters (e.g. dopamine) to modulate the cellular metabolism of the brain.
This project will impact opioid addiction and related neuroscience and impact the broader research of drug development involving different diseases, organs, and preclinical models. The proposed imaging platform will be generally applicable to drug screening and discovery through preclinical imaging when the opioid is replaced by the drug of interest.
The results of this project will be shared amongst the scientific/engineering and pharmaceutical
communities, and across wide segments of society in outreach activities. The new imaging and
visualization capabilities will inspire K-12 students to think about how technology can be used to benefit scientific investigations. Outreach activities will include demonstrations of this imaging platform to community groups through annual Engineering Open House events, as well as integration of these technological methods in Prof. Boppart's undergraduate Biophotonics and Biomedical Imaging courses.
This award reflects NSF's statutory mission and has been deemed worthy of support through evaluation using the Foundation's intellectual merit and broader impacts review criteria.
PUBLICATIONS PRODUCED AS A RESULT OF THIS RESEARCH
Note:
When clicking on a Digital Object Identifier (DOI) number, you will be taken to an external
site maintained by the publisher. Some full text articles may not yet be available without a
charge during the embargo (administrative interval).
Some links on this page may take you to non-federal websites. Their policies may differ from
this site.
PROJECT OUTCOMES REPORT
Disclaimer
This Project Outcomes Report for the General Public is displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed in this Report are those of the PI and do not necessarily reflect the views of the National Science Foundation; NSF has not approved or endorsed its content.
This project, entitled Optical Molecular Imaging of Opioid Distribution and its Metabolic Effects in the Brain, set out to construct a new optical imaging microscope that was sensitive to not only microscopic structures of neurons (cells) in brain tissue, but also sensitive to the molecular composition and the metabolic dynamics that take place in these brain cells in health and after exposure to morphine, an opioid. Because of the significant negative impact that opioids have had on individual lives and on our society, our goal was to develop and use new imaging technologies to image neurons and brain slices from a rodent model before and after exposure to morphine, to determine what changes occur. The intellectual merit of our project consisted of new optical imaging technologies and ways to visualize the effects that opioids have on the brain. We constructed several types of optical imaging systems and characterized their sensitivity, spectral resolution, and spectral fidelity. We also applied our microscopy techniques to characterize the optical properties or signatures of opioids (morphine), so we could then look for these signatures and the presence of morphine in cells or tissues. Our imaging showed the capacity to visualize metabolic brain cell activity after morphine treatment, and revealed different responses from different brain slice regions following the administration of morphine to the brain slice preparations.
We further worked to improve the sensitivity of our microscope by implementing a better detection process, and improve multi-modality capabilities by adding other optical signal channels. This was done by adding more detectors and filters to the microscope so multiple channels could be detected simultaneously, allowing us to rapidly detect the metabolic activity within the cells or tissues. For brain slice imaging, we improved parameters that allowed us to capture high-resolution images over larger areas of tissue. This allowed us to image different parts of the rodent brain to study the morphine effects across different regions. We then spent considerable time investigating morphine interactions with cultured neurons, isolated brain cells grown and maintained in a dish, since these were a much simpler system to investigate interactions and changes related to neuronal metabolism.
Finally, we focused on imaging at even higher resolution within single cells to understand the morphine effect on neurons and glial cell metabolism by tracking the sub-cellular movement and signals from mitochondria, parts of the cell that are responsible for powering cell function, including metabolism. We constructed a hybrid microscope for simultaneous imaging and developed analysis methods to statistically quantify the amount and dynamics of metabolic changes happening in the cells. Using these tools, we found an increase in metabolic intensity and a decrease in mitochondria size by label-free imaging, when the neurons were exposed to morphine. We correlated these observations and proposed the mechanism of how morphine interacts with neurons and glial cells in the brain. The broader impact of our work will influence the fields of optical science and engineering, biophotonics, and neuroscience, as we learn more about the effects that opioids have on the brain structure, metabolism, and function. In the future, our label-free imaging tools and discoveries will help scientists to better understand how opioids interact across many spatial scales, from the sub-cellular and cellular level with neurons and glia, as well as across larger connected brain regions.
Last Modified: 08/16/2020
Modified by: Stephen A Boppart
Please report errors in award information by writing to: awardsearch@nsf.gov.